Financial Analysis

Celltrion (068270.KS) Q1 Profit Doubles on Biosimilar Surge

Celltrion's Q1 operating profit more than doubled to 321.9 billion won as biosimilar sales drove revenue up 28% to a record 1.145 trillion won.

NAVER (035420.KS), Kakao Hit Record Q1 but Lag KOSPI Rally

Kakao Games Q1 Loss Doubles to ₩25.5B as New-Title Drought Drags Revenue Down 33%

Hanmi Pharmaceutical Q1 Operating Profit Falls 9.1% as China Unit Doubles, Holding Co. Climbs 24%

LG Energy Solution posts ₩207.8 billion Q1 loss; LG Chem swings to deficit

Samsung's Chip Arm Posts Record ₩53.7 Trillion Q1 Profit as HBM4 Ramps for Nvidia

APR (278470.KS) FY2025 Financial Analysis: 111% Revenue Surge & 3x Profit Growth

Samsung SDI Q1 2026 Operating Loss Narrows to ₩155.6 Billion, Beats Street Forecasts

Doosan Robotics FY2025 Financials: Revenue –29.6%, Operating Loss Widens ₩59.4B

SK Hynix FY2025 Analysis: ₩97T Revenue, 48.6% OPM Record

Hyundai Mobis FY2025 Financial Report: Profit Divergence

Ottogi FY2025 Financial Analysis: Revenue Growth Despite 20% Operating Profit Plunge